Cargando…

Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis

BACKGROUND: Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adeyemi, Oladipupo, Alvarez-Laviada, Anita, Schultz, Francisca, Ibrahim, Effendi, Trauner, Michael, Williamson, Catherine, Glukhov, Alexey V., Gorelik, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608194/ https://www.ncbi.nlm.nih.gov/pubmed/28934223 http://dx.doi.org/10.1371/journal.pone.0183167

Ejemplares similares

Prolonged ursodeoxycholic acid administration reduces acute ischaemia-induced arrhythmias in adult rat hearts
por: Ferraro, Elisa, et al.
Publicado: (2020)

Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression
por: Kim, Min Ju, et al.
Publicado: (2018)

Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis
por: Gurung, Vinita, et al.
Publicado: (2009)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
por: Fleminger, J, et al.
Publicado: (2020)

Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
por: Lewis, Tamorah, et al.
Publicado: (2018)

The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model
por: Ainosah, Randa H., et al.
Publicado: (2020)

Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022)

The Reversed Feto-Maternal Bile Acid Gradient in Intrahepatic Cholestasis of Pregnancy Is Corrected by Ursodeoxycholic Acid
por: Geenes, Victoria, et al.
Publicado: (2014)

Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment
por: Pataia, Vanessa, et al.
Publicado: (2018)

Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid
por: Joutsiniemi, Titta, et al.
Publicado: (2015)

Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis
por: Zhang, Yang, et al.
Publicado: (2016)

Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis
por: Dong, Xiao-Rui, et al.
Publicado: (2023)

Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial
por: Chappell, Lucy C, et al.
Publicado: (2019)

Feto-Maternal Effects of Adding Rifampicin to Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
por: Kumari, Anjali, et al.
Publicado: (2022)

Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis
por: Huang, Liang, et al.
Publicado: (2023)

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
por: Ovadia, Caroline, et al.
Publicado: (2021)

Drug Resistant Fetal Arrhythmia in Obstetric Cholestasis
por: Altug, Nahide, et al.
Publicado: (2015)

Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial
por: Chappell, Lucy C, et al.
Publicado: (2012)

Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study
por: Kotb, Magd Ahmed, et al.
Publicado: (2020)

Recent advances in understanding and managing cholestasis
por: Wagner, Martin, et al.
Publicado: (2016)

Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy
por: Kukla, Michał, et al.
Publicado: (2021)

Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study
por: Manna, LB, et al.
Publicado: (2019)

Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES)
por: Chappell, Lucy C., et al.
Publicado: (2018)

Total Beta-Adrenoceptor Knockout Slows Conduction and Reduces Inducible Arrhythmias in the Mouse Heart
por: Stöckigt, Florian, et al.
Publicado: (2012)

Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn
por: Teng, Jonas, et al.
Publicado: (2022)

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)
por: Kong, Xiang, et al.
Publicado: (2016)

CT Image Features under Reconstruction Algorithm in Analysis of the Effect of Probiotics Combined with Ursodeoxycholic Acid in Treatment of Intrahepatic Cholestasis of Pregnancy
por: Liu, Hongxue, et al.
Publicado: (2021)

Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis
por: Wang, Yan, et al.
Publicado: (2021)

Automatic Detection of Slow Conducting Channels during Substrate Ablation of Scar-Related Ventricular Arrhythmias
por: Alcaine, Alejandro, et al.
Publicado: (2020)

High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
por: Azzaroli, Francesco, et al.
Publicado: (2013)

Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study): Erratum
Publicado: (2017)

Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations.
por: Trauner, M.
Publicado: (1997)

Opto-SICM framework combines optogenetics with scanning ion conductance microscopy for probing cell-to-cell contacts
por: Song, Qianqian, et al.
Publicado: (2023)

Editorial: Cardiomyocyte Microdomains: An Emerging Concept of Local Regulation and Remodeling
por: Lang, Di, et al.
Publicado: (2020)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Severe Intrahepatic Cholestasis of Pregnancy—Potential Mechanism by Which Fetuses Are Protected from the Hazardous Effect of Bile Acids
por: Hershkovitz, Gal, et al.
Publicado: (2023)

Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice
por: Truong, Jennifer K., et al.
Publicado: (2023)

Microdomain-Specific Modulation of L-Type Calcium Channels Leads to Triggered Ventricular Arrhythmia in Heart Failure
por: Sanchez-Alonso, Jose L., et al.
Publicado: (2016)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients
por: Mueller, Michaela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_es6i5qclkfoo6jetd4qb5jao4m